The Ohio State University, commonly Ohio State or OSU, is a public land-grant research university in Columbus, Ohio. The flagship of the University System of Ohio, it has been ranked by major institutional rankings among the best public universities in the United States.

During the past decade, Ohio State University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ohio State University" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Celgene" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Regeneron Pharmaceuticals" with 1 trials sponsored and "Shari L Hand" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio State University" #1 collaborator was "Agios Pharmaceuticals, Inc." with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator, "The Leukemia and Lymphoma Society" with 1 trials as a collaborator and "Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ohio State University" are "Plaque Psoriasis" (2 trials), "Atopic Dermatitis" (1 trials), "Cutaneous Squamous Cell Carcinoma" (1 trials), "Eczema" (1 trials) and "Hand Eczema" (1 trials). Many other conditions were trialed in "Ohio State University" in a lesser frequency.

Most popular intervention types in "Ohio State University" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (2 trials), "Ixekizumab" (2 trials), "CLn BodyWash" (1 trials) and "Cemiplimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ohio State University" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Ohio State University". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ohio State University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio State University, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".